Medical research

A promising therapeutic modality against the coronavirus

Since the emergence of the novel coronavirus in late 2019, multiple approaches for treating COVID-19 have been considered, from the use of repurposed medicines such as the antimalarial drug, hydroxychloroquine, to the Ebola ...

Diseases, Conditions, Syndromes

WHO halts hydroxychloroquine trials on COVID-19 patients

The World Health Organization decided Wednesday to halt trials of hydroxychloroquine as a potential treatment for hospitalised COVID-19 patients, finding it did not reduce the mortality rate.


Side effects seen with use of chloroquine against COVID-19

(HealthDay)—The use of the antimalarial drug chloroquine to treat COVID-19 patients has been halted at several Swedish hospitals due to reported side effects such as cramps and loss of peripheral vision. Sahlgrenska University ...

page 1 from 8